Myeloid STAT3 Inhibits T Cell-Mediated Hepatitis by Regulating T Helper 1 Cytokine and Interleukin-17 Production

Gastroenterology

Volumn 137, Issue 6, 2009, Pages

  Lafdil, Fouad ^a   Wang, Hua ^a   Park, Ogyi ^a   Zhang, Weici ^b   Moritoki, Yuki ^b   Yin, Shi ^a   Fu, Xin Yuan ^c   Gershwin, M Eric ^b   Lian, Zhe Xiong ^b   Gao, Bin ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 22; STAT1 PROTEIN; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEPATITIS; LIVER FAILURE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH17 CELL;

EID: 70749102261     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.08.004     Document Type: Article

References (47)

1. Chang K.M. Immunopathogenesis of hepatitis C virus infection. Clin Liver Dis 7 (2003) 89-105
2. Rehermann B. Intrahepatic T cells in hepatitis B: viral control versus liver cell injury. J Exp Med 191 (2000) 1263-1268
3. Diamantis I., and Boumpas D.T. Autoimmune hepatitis: evolving concepts. Autoimmun Rev 3 (2004) 207-214
4. He X.S., Ansari A.A., Ridgway W.M., et al. New insights to the immunopathology and autoimmune responses in primary biliary cirrhosis. Cell Immunol 239 (2006) 1-13
5. Thiele G.M., Freeman T.L., and Klassen L.W. Immunologic mechanisms of alcoholic liver injury. Semin Liver Dis 24 (2004) 273-287
6. Caldwell C.C., Tschoep J., and Lentsch A.B. Lymphocyte function during hepatic ischemia/reperfusion injury. J Leukoc Biol 82 (2007) 457-464
7. Rosen H.R. Transplantation immunology: what the clinician needs to know for immunotherapy. Gastroenterology 134 (2008) 1789-1801
8. Tiegs G., Hentschel J., and Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 90 (1992) 196-203
9. Tiegs G. Cellular and cytokine-mediated mechanisms of inflammation and its modulation in immune-mediated liver injury. Z Gastroenterol 45 (2007) 63-70
10. Takeda K., Hayakawa Y., Van Kaer L., et al. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci U S A 97 (2000) 5498-5503
11. Nakashima H., Kinoshita M., Nakashima M., et al. Superoxide produced by Kupffer cells is an essential effector in concanavalin A-induced hepatitis in mice. Hepatology 48 (2008) 1979-1988
12. Bonder C.S., Ajuebor M.N., Zbytnuik L.D., et al. Essential role for neutrophil recruitment to the liver in concanavalin A-induced hepatitis. J Immunol 172 (2004) 45-53
13. Louis H., Le Moine A., Flamand V., et al. Critical role of interleukin 5 and eosinophils in concanavalin A-induced hepatitis in mice. Gastroenterology 122 (2002) 2001-2010
14. Jaruga B., Hong F., Sun R., et al. Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes. J Immunol 171 (2003) 3233-3244
15. Hong F., Jaruga B., Kim W.H., et al. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J Clin Invest 110 (2002) 1503-1513
16. Zenewicz L.A., Yancopoulos G.D., Valenzuela D.M., et al. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27 (2007) 647-659
17. Nagata T., McKinley L., Peschon J.J., et al. Requirement of IL-17RA in Con A induced hepatitis and negative regulation of IL-17 production in mouse T cells. J Immunol 181 (2008) 7473-7479
18. Gantner F., Leist M., Lohse A.W., et al. Concanavalin A-induced T cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21 (1995) 190-198
19. Radaeva S., Sun R., Pan H.N., et al. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39 (2004) 1332-1342
20. Erhardt A., Biburger M., Papadopoulos T., et al. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology 45 (2007) 475-485
21. Sun R., Park O., Horiguchi N., et al. STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice. Hepatology 44 (2006) 955-966
22. Siebler J., Wirtz S., Klein S., et al. A key pathogenic role for the STAT1/T-bet signaling pathway in T cell-mediated liver inflammation. Hepatology 38 (2003) 1573-1580
23. Klein C., Wustefeld T., Assmus U., et al. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury. J Clin Invest 115 (2005) 860-869
24. Luedde T., Assmus U., Wustefeld T., et al. Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury. J Clin Invest 115 (2005) 849-859
25. Beraza N., Ludde T., Assmus U., et al. Hepatocyte-specific IKK γ/NEMO expression determines the degree of liver injury. Gastroenterology 132 (2007) 2504-2517
26. Maeda S., Chang L., Li Z.W., et al. IKKβ is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFα. Immunity 19 (2003) 725-737
27. Sakamori R., Takehara T., Ohnishi C., et al. Signal transducer and activator of transcription 3 signaling within hepatocytes attenuates systemic inflammatory response and lethality in septic mice. Hepatology 46 (2007) 1564-1573
28. Haga S., Terui K., Zhang H.Q., et al. Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J Clin Invest 112 (2003) 989-998
29. Das M., Sabio G., Jiang F., et al. Induction of hepatitis by JNK-mediated expression of TNF-α. Cell 136 (2009) 249-260
30. Matsukawa A., Kudo S., Maeda T., et al. Stat3 in resident macrophages as a repressor protein of inflammatory response. J Immunol 175 (2005) 3354-3359
31. Chen Z., Laurence A., and O'Shea J.J. Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation. Semin Immunol 19 (2007) 400-408
32. Dong C. Regulation and pro-inflammatory function of interleukin-17 family cytokines. Immunol Rev 226 (2008) 80-86
33. Ouyang W., Kolls J.K., and Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28 (2008) 454-467
34. Jaruga B., Hong F., Kim W.H., et al. IFN-{γ}/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1. Am J Physiol Gastrointest Liver Physiol 287 (2004) G1044-G1052
35. Geisler F., Algul H., Paxian S., et al. Genetic inactivation of RelA/p65 sensitizes adult mouse hepatocytes to TNF-induced apoptosis in vivo and in vitro. Gastroenterology 132 (2007) 2489-2503
36. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3 (2003) 133-146
37. Siebler J., Wirtz S., Frenzel C., et al. Cutting edge: a key pathogenic role of IL-27 in T cell-mediated hepatitis. J Immunol 180 (2008) 30-33
38. Lucas S., Ghilardi N., Li J., et al. IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 100 (2003) 15047-15052
39. Bender H., Wiesinger M.Y., Nordhoff C., et al. Interleukin-27 displays interferon-γ-like functions in human hepatoma cells and hepatocytes. Hepatology 50 (2009) 585-591
40. Yoshida H., and Miyazaki Y. Interleukin 27 signaling pathways in regulation of immune and autoimmune responses. Int J Biochem Cell Biol 40 (2008) 2379-2383
41. Wolk K., and Sabat R. Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 17 (2006) 367-380
42. Ansel K.M., Djuretic I., Tanasa B., et al. Regulation of Th2 differentiation and Il4 locus accessibility. Annu Rev Immunol 24 (2006) 607-656
43. Zocco M.A., Carloni E., Pescatori M., et al. Characterization of gene expression profile in rat Kupffer cells stimulated with IFN-α or IFN-γ. Dig Liver Dis 38 (2006) 563-577
44. Lemmers A., Moreno C., Gustot T., et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 49 (2009) 646-657
45. Witowski J., Pawlaczyk K., Breborowicz A., et al. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO α chemokine from mesothelial cells. J Immunol 165 (2000) 5814-5821
46. Laan M., Cui Z.H., Hoshino H., et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 162 (1999) 2347-2352
47. Yu Z., and Kone B.C. The STAT3 DNA-binding domain mediates interaction with NF-κB p65 and inducible nitric oxide synthase transrepression in mesangial cells. J Am Soc Nephrol 15 (2004) 585-591